Image
26.08.2021
Batch of liquid metformin recalled by MHRA
The Medicines and Healthcare products Regulatory Agency (MHRA) warned yesterday that one batch (batch num...
customer support
customer support
From research findings supporting SGLT-2 inhibitors as a first-choice type 2 treatment to a real-world study strengthening evidence for teplizumab in early type 1, here are some of the diabetes research developments announced in February 2026.
Read more